Format

Send to:

Choose Destination
See comment in PubMed Commons below
Ann Oncol. 2004 Oct;15(10):1453-9.

New options and old dilemmas in the treatment of patients with advanced colorectal cancer.

Author information

  • 1Department of Medical Oncology, University Medical Center St Radboud, Nijmegen, The Netherlands. c.punt@onco.umcn.nl

Abstract

With more data on the use of oxaliplatin and irinotecan available, and the recent approval of two signal transduction inhibitors for patients with advanced colorectal cancer, there are now many treatment options to choose from. From the current regimens no straightforward choice can be made that provides any patient with the optimal chance for prolonged survival with the least side-effects. The current data concerning timing and duration of chemotherapy, combination or sequential therapy, preference of agents for first-line treatment, oral fluoropyrimidines, neo-adjuvant chemotherapy for irresectable liver metastases, and the use of signal transduction inhibitors are reviewed.

PMID:
15367403
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk